Orthopediatrics (KIDS) Cash & Current Investments (2016 - 2026)
Orthopediatrics' (KIDS) quarterly Cash & Current Investments came in at $14.2 million in Q1 2026, down 75.76% year-on-year from $58.8 million in Q1 2025, and down 76.59% on a QoQ basis from $60.9 million in Q4 2025.
Orthopediatrics (KIDS) Cash & Current Investments (2016 - 2026) Analysis & Trends
Orthopediatrics (KIDS) has 11 years of Cash & Current Investments data on file, last reported at $14.2 million in Q1 2026.
- On a quarterly basis, Cash & Current Investments fell 75.76% year-over-year to $14.2 million in Q1 2026; TTM through Mar 2026 was $14.2 million, a 75.76% decrease from a year earlier, with the FY2025 full-year figure at $60.9 million, down 11.6% from the prior year.
- Cash & Current Investments for Q1 2026 stood at $14.2 million, down from $60.9 million in the prior quarter.
- Over the last five years, Cash & Current Investments for KIDS reached as high as $118.3 million in Q4 2022 and fell as low as $11.3 million in Q2 2023.
- Historically, Cash & Current Investments has averaged $52.8 million across 5 years, with a median of $53.0 million in 2024.
- Across the five-year window, Cash & Current Investments soared 999.84% in 2022 and sank 85.56% in 2023, its largest moves.
- Year by year, Cash & Current Investments stood at $118.3 million in 2022, then plunged by 72.08% to $33.0 million in 2023, then jumped by 108.41% to $68.8 million in 2024, then retreated by 11.6% to $60.9 million in 2025, then plunged by 76.59% to $14.2 million in 2026.
- Per Business Quant data, the three most recent Cash & Current Investments figures were $14.2 million in Q1 2026, $60.9 million in Q4 2025, and $57.7 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash & Current Investments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | 7.30 Bn |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | 2.88 Bn |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | 9.22 Bn |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | 1.45 Bn |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | 3.67 Bn |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | 1.12 Bn |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | 2.29 Bn |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | 577.00 Mn |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | 3.12 Bn |
| 10 | Orthopediatrics | 468.25 Mn | 454.01 Mn | 43.39 Mn | 14.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 14.25 Mn |
| Dec 31, 2025 | 60.85 Mn |
| Sep 30, 2025 | 57.73 Mn |
| Jun 30, 2025 | 70.15 Mn |
| Mar 31, 2025 | 58.77 Mn |
| Dec 31, 2024 | 68.83 Mn |
| Sep 30, 2024 | 53.05 Mn |
| Jun 30, 2024 | 28.93 Mn |
| Mar 31, 2024 | 47.74 Mn |
| Dec 31, 2023 | 33.03 Mn |
| Sep 30, 2023 | 12.23 Mn |
| Jun 30, 2023 | 11.31 Mn |
| Mar 31, 2023 | 107.73 Mn |
| Dec 31, 2022 | 118.29 Mn |
| Sep 30, 2022 | 84.71 Mn |
| Jun 30, 2022 | 51.16 Mn |
| Mar 31, 2022 | 19.32 Mn |
| Dec 31, 2021 | 53.54 Mn |
| Sep 30, 2021 | 7.70 Mn |
| Jun 30, 2021 | 65.85 Mn |